Skip to main content
. 2020 Aug 26;10(9):637. doi: 10.3390/diagnostics10090637

Table 2.

Summary of Meta-Analytic Results.

K N Overall Rate of WT1 Expression
(95% CI), %
Q I2
Endometroid Carcinoma 23 985 21 (16−29) 117.07 81.21
Serous Carcinoma 17 307 21 (14−29) 42.3 62.2
Clear Cell Carcinoma 6 59 15 (6−33) 6.99 28.4
Carcinosarcoma 6 240 38 (33−43) 2.31 0.00

K: number of studies; N: total number of patients; CI: confidence interval; I2: index for quantifying the degree of heterogeneity; Q: test for heterogeneity; p < 0.001.